Collateral sensitivity to gemcitabine (2′,2′-difluorodeoxycytidine) and cytosine arabinoside of daunorubicin- and VM-26-resistant variants of human small cell lung cancer cell lines
Andries M. Bergman, Birgitte Munch-Petersen, Peter Buhl Jensen, Maxwell Sehested, Gijsbert Veerman, Daphne A. Voorn, Kees Smid, Herbert M. Pinedo, Godefridus J. Peters
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Collateral sensitivity to gemcitabine (2′,2′-difluorodeoxycytidine) and cytosine arabinoside of daunorubicin- and VM-26-resistant variants of human small cell lung cancer cell lines'. Together they form a unique fingerprint.